V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 330007212 | 330004004 | 1.74 | 84.6 | Curative (C) | 2016-03-02 | 2016-03-09 | Rituximab | N | N | 330008198 | RITUXIMAB |
| 330007213 | 330004006 | null | 0 | Palliative (P) | 2014-07-16 | 2014-07-30 | Rituximab (Maintenance) | N | Y | 330008198 | RITUXIMAB |
| 330007214 | 330004007 | 1.68 | 24.6 | Curative (C) | 2014-08-04 | 2014-08-04 | Rituximab | 02 | N | 330008208 | RITUXIMAB |
| 330007215 | 330004010 | 1.75 | 70.7 | Neo-adjuvant (N) | 2013-10-05 | 2013-10-05 | DOCETAXEL + GEMCITABINE | null | null | 330008219 | DOCETAXEL + GEMCITABINE |
| 330007216 | 330004012 | 1.82 | 121.2 | null | 2018-05-28 | 2018-06-14 | OST Euramos 1 Closed Trial - M | 02 | N | 330008231 | METHOTREXATE HIGH DOSE |
| 330007217 | 330004013 | 1.72 | 77.7 | Neo-adjuvant (N) | 2017-02-27 | 2017-04-15 | CISPLATIN + FLUOROURACIL | null | null | 330008235 | CISPLATIN + FLUOROURACIL |
| 330007218 | 330004017 | 1.68 | 52 | Curative (C) | null | 2015-05-05 | OST Euramos 1 Closed Trial - M | N | N | 330008235 | METHOTREXATE HIGH DOSE |
| 330007219 | 330004017 | 1.82 | 71.6 | Curative (C) | null | 2015-11-09 | MAP | Y | N | 330008235 | MAP |
| 330007220 | 330004017 | 1.83 | 60.8 | null | 2016-12-04 | 2016-12-04 | Cetuximab 7 day (>Cycle 2) | N | N | 330008235 | CETUXIMAB |
| 330007221 | 330004018 | 1.69 | 96.7 | Neo-adjuvant (N) | 2017-03-29 | 2017-04-11 | ETOPOSIDE + IFOSFAMIDE | N | N | 330008263 | ETOPOSIDE + IFOSFAMIDE |
| 330007222 | 330008188 | null | 60.5 | Neo-adjuvant (N) | 2014-07-02 | 2014-07-11 | CISPLATIN + FLUOROURACIL | Y | N | 330008265 | CISPLATIN + FLUOROURACIL |
| 330007223 | 330008188 | 2 | 51.3 | Curative (C) | 2017-05-12 | 2017-05-21 | MAP | 2 | N | 330008265 | MAP |
| 330007224 | 330004023 | 0 | 49 | null | 2015-10-23 | 2015-10-23 | PAM x 2 post-surgery (cycles 3&4) | 1 | N | 330008268 | MAP |
| 330007225 | 330004025 | 1.71 | 82.3 | Palliative (P) | 2014-04-25 | 2014-08-01 | DOCETAXEL + GEMCITABINE | 02 | N | 330008268 | DOCETAXEL + GEMCITABINE |
| 330007226 | 330010445 | 1.75 | 77.7 | Neo-adjuvant (N) | 2013-10-08 | 2013-11-20 | CETUXIMAB | N | null | 330008273 | CETUXIMAB |
| 330007227 | 330004026 | 1.63 | 51.3 | null | 2015-09-10 | 2015-09-15 | Carboplatin AUC 6 - 10 | N | N | 330008281 | CARBOPLATIN |
| 330007228 | 330008190 | 1.6 | 75.1 | null | 2016-07-02 | 2016-08-15 | OST Euramos 1 Closed Trial - M | 02 | N | 330008284 | METHOTREXATE HIGH DOSE |
| 330007229 | 330004029 | 1.62 | null | Neo-adjuvant (N) | 2017-05-15 | 2017-06-05 | Cisplatin +Fluorouracil (3 wk) | N | N | 330008290 | CISPLATIN + FLUOROURACIL |
| 330007230 | 330004029 | 1.72 | 90.5 | Curative (C) | 2013-10-18 | 2013-11-22 | Methotrexate High Dose (3g/m2) | 02 | N | 330008290 | METHOTREXATE HIGH DOSE |
| 330007231 | 330004030 | 1.62 | 48.4 | null | 2014-09-09 | 2014-09-10 | OST Euramos 1 Closed Trial - M | N | N | 330008298 | METHOTREXATE HIGH DOSE |
| 330007232 | 330008195 | null | 76.25 | Curative (C) | 2015-01-14 | 2015-02-11 | Cisplatin +Fluorouracil (3 wk) | N | N | 330008299 | CISPLATIN + FLUOROURACIL |
| 330007233 | 330004033 | null | null | Palliative (P) | 2015-01-09 | 2015-01-24 | DOCETAXEL + GEMCITABINE | null | N | 330008302 | DOCETAXEL + GEMCITABINE |
| 330007234 | 330004033 | 1.8 | null | Curative (C) | 2015-09-21 | 2015-11-12 | OST Euramos 1 Closed Trial - M | N | N | 330008302 | METHOTREXATE HIGH DOSE |
| 330007235 | 330004034 | 1.6 | null | null | 2016-08-24 | 2016-10-03 | Docetaxel + Gemcitabine (prior RT) | N | N | 330008305 | DOCETAXEL + GEMCITABINE |
| 330007236 | 330010448 | 1.65 | 51 | null | 2013-03-22 | 2013-03-29 | Docetaxel + Gemcitabine (prior RT) | 2 | N | 330008309 | DOCETAXEL + GEMCITABINE |
| 330007237 | 330010448 | 1.62 | 96.7 | Curative (C) | null | 2017-01-10 | Cetuximab 7 day (>Cycle 2) | N | N | 330008309 | CETUXIMAB |
| 330007238 | 330004035 | 1.78 | 136.5 | null | 2013-12-23 | 2014-01-27 | Rituximab (SUBCUTANEOUS Maintenance) | N | N | 330008317 | RITUXIMAB |
| 330007239 | 330004035 | null | 58 | Curative (C) | 2016-05-25 | 2017-01-04 | OST Euramos 1 Closed Trial - M | N | N | 330008317 | METHOTREXATE HIGH DOSE |
| 330007240 | 330004036 | 1.75 | 6.4 | Palliative (P) | null | 2017-07-07 | Docetaxel + Gemcitabine with GCSF | 02 | null | 330008321 | DOCETAXEL + GEMCITABINE |
| 330007241 | 330004037 | 1.81 | 75.1 | Neo-adjuvant (N) | 2017-10-23 | 2017-11-13 | Docetaxel + Gemcitabine (prior RT) | 2 | N | 330008351 | DOCETAXEL + GEMCITABINE |
| 330007242 | 330004037 | 1.65 | 49.8 | Palliative (P) | null | 2018-04-26 | Docetaxel + Gemcitabine (prior RT) | N | null | 330008351 | DOCETAXEL + GEMCITABINE |
| 330007244 | 330004040 | 0 | 90.5 | Palliative (P) | 2014-02-20 | 2014-03-26 | CISPLATIN + FLUOROURACIL | N | N | 330008365 | CISPLATIN + FLUOROURACIL |
| 330007245 | 330004041 | 1.74 | null | Palliative (P) | 2017-06-26 | 2017-07-20 | Methotrexate High Dose (3g/m2) | 02 | N | 330008365 | METHOTREXATE HIGH DOSE |
| 330007246 | 330004044 | 1.63 | 30.4 | Palliative (P) | 2015-02-17 | 2015-03-24 | DOCETAXEL + GEMCITABINE | 02 | N | 330008370 | DOCETAXEL + GEMCITABINE |
| 330007247 | 330004044 | 1.5 | 51.3 | Adjuvant (A) | 2016-04-23 | 2016-04-23 | PAM x 2 pre-surgery (cycles 1&2) | 2 | N | 330008370 | MAP |
| 330007249 | 330008204 | null | 54.6 | Palliative (P) | 2016-11-10 | 2016-12-06 | CETUXIMAB | 02 | N | 330008382 | CETUXIMAB |
| 330007250 | 330004051 | 1.67 | 67.3 | Palliative (P) | 2015-04-14 | 2015-04-14 | Cetuximab 7 day (>Cycle 2) | N | N | 330008383 | CETUXIMAB |
| 330007251 | 330004053 | 1.7 | 53.4 | Palliative (P) | 2018-01-30 | 2018-01-30 | CISPLATIN + FLUOROURACIL | N | Y | 330008390 | CISPLATIN + FLUOROURACIL |
| 330007252 | 330008208 | 1.91 | 73.1 | Neo-adjuvant (N) | 2015-05-22 | 2015-05-27 | Etoposide + Ifosfamide (3 days) | 02 | N | 330008395 | ETOPOSIDE + IFOSFAMIDE |
| 330007253 | 330004057 | 1.64 | 44.3 | Curative (C) | 2016-11-25 | 2016-11-27 | Methotrexate High Dose (3g/m2) | 02 | N | 330008395 | METHOTREXATE HIGH DOSE |
| 330007254 | 330004059 | 1.65 | null | Palliative (P) | 2014-05-19 | 2014-05-19 | Docetaxel+Gemcitabine (no prior RT) | 2 | N | 330008399 | DOCETAXEL + GEMCITABINE |
| 330007255 | 330008211 | 1.59 | 67.5 | Palliative (P) | 2015-09-22 | 2015-09-22 | CISPLATIN + FLUOROURACIL | N | N | 330008410 | CISPLATIN + FLUOROURACIL |
| 330007256 | 330004060 | 1.6 | 74.9 | Palliative (P) | 2015-12-12 | 2015-12-17 | DOCETAXEL + GEMCITABINE | 02 | null | 330008427 | DOCETAXEL + GEMCITABINE |
| 330007257 | 330004060 | 1.7 | 112 | Palliative (P) | 2013-07-29 | 2013-12-23 | Cisplatin +Fluorouracil (3 wk) | 02 | N | 330008427 | CISPLATIN + FLUOROURACIL |
| 330007258 | 330004061 | 1.75 | 73.1 | Palliative (P) | 2017-02-13 | 2017-02-19 | CETUXIMAB | 02 | N | 330008439 | CETUXIMAB |
| 330007259 | 330004062 | 1.65 | 57.8 | Palliative (P) | 2018-01-22 | 2018-01-22 | CISPLATIN + FLUOROURACIL | N | N | 330008443 | CISPLATIN + FLUOROURACIL |
| 330007260 | 330008213 | 1.73 | 111.3 | Curative (C) | 2017-04-16 | 2017-04-29 | Docetaxel + Gemcitabine (prior RT) | N | N | 330008443 | DOCETAXEL + GEMCITABINE |
| 330007261 | 330008213 | 1.69 | 86.8 | Palliative (P) | 2015-01-24 | 2015-01-24 | PAM x 2 post-surgery (cycles 3&4) | N | N | 330008443 | MAP |
| 330007262 | 330004064 | 1.68 | null | Palliative (P) | null | 2016-12-07 | DOCETAXEL + GEMCITABINE | null | null | 330008466 | DOCETAXEL + GEMCITABINE |
| 330007264 | 330004065 | 1.78 | 90 | Disease modification (D) | 2018-01-02 | 2018-01-02 | Methotrexate High Dose (3g/m2) | 02 | N | 330008495 | METHOTREXATE HIGH DOSE |